---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-013294"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:21:36.197887+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NeuroOne Q1 revenue jumps to $978k; OneRF Ablation System receives FDA clearance

## Summary
- Product revenue $978k in Q1 fiscal 2024, up from $115k in Q1 2023.
- Net loss $3.3M vs $1.7M YoY; cash $2.7M at Dec 31, 2023.
- FDA 510(k) clearance for OneRF Ablation System in Dec 2023; limited commercial launch expected Q2 2024.
- Zimmer Biomet sales force trained for Evo sEEG; new accounts expected to drive revenue growth.
- Raised $2.8M via ATM offering at avg $1.45/share in Dec 2023 – Jan 2024.

## SEC filing metadata
- accession: 0001213900-24-013294
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390024013294/0001213900-24-013294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390024013294/ea193484-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-013294
- JSON: https://secwatch.observer/filing/0001213900-24-013294.json
- Plain text: https://secwatch.observer/filing/0001213900-24-013294.txt

## Key facts
- Earnings Releases
  NEUROONE MEDICAL TECHNOLOGIES Corp reported financial results for first quarter fiscal year 2024 ended December 31, 2023.
  - Period: first quarter fiscal year 2024 ended December 31, 2023
  - Result: reported results
  source text: On February 13, 2024, NeuroOne Medical Technologies Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1500198/000121390024013294/0001213900-24-013294-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.